IP Verse

Euro Celtique competitive analysis

Loading summary...

Latest patents of Euro Celtique opposed by its competitors

Explore Euro Celtique's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3578173
Oct 26, 2022Dosage Form Containing Oxycodone And Naloxone5
EP2568967
Jul 27, 2022Pharmaceutical Compositions Comprising Hydromorphone And Naloxone2
EP2706982
Mar 10, 2021Intranasal Pharmaceutical Dosage Forms Comprising Naloxone1
EP3024461
May 13, 2020A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation2
EP2962686
Apr 10, 2019Dosage Form Containing Oxycodone And Naloxone7
EP2568968
Jul 12, 2017Manufacturing Of Active-Free Granules And Tablets Comprising The Same1
EP2425821
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
EP2425824
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
EP1586311
May 3, 2017Melt Extrusion Of Multiparticulates1
EP1731152
May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine3

Latest publications and patents of Euro Celtique New

Explore the latest publications and patents granted to Euro Celtique, showcasing their recent innovations and technological advancements.

Last updated on: Oct 16, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Euro Celtique

EP3578173
Oct 26, 2022Dosage Form Containing Oxycodone And NaloxoneGranted And Under Opposition
EP2568967
Jul 27, 2022Pharmaceutical Compositions Comprising Hydromorphone And NaloxonePatent Maintained As Amended
EP2706982
Mar 10, 2021Intranasal Pharmaceutical Dosage Forms Comprising NaloxonePatent Maintained As Amended
EP3024461
May 13, 2020A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial TranslocationRevoked
EP2962686
Apr 10, 2019Dosage Form Containing Oxycodone And NaloxoneRevoked
EP2269595
Jan 31, 2018Titratable Dosage Transdermal Delivery SystemNo Opposition Filed Within Time Limit
EP2316837
Jan 10, 2018Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-HydroxycodeinoneNo Opposition Filed Within Time Limit
EP2568968
Jul 12, 2017Manufacturing Of Active-Free Granules And Tablets Comprising The SameRevoked
EP2425824
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneRevoked
EP2425821
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneRevoked

Latest PTAB cases involving Euro Celtique

Discover the latest PTAB cases involving Euro Celtique, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Euro Celtique with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EURO CELTIQUE - 44 - -
DEVELCO PHARMA SCHWEIZ5 - - -
ETHYPHARM112 - -
HEXAL SANDOZ5 - - -